SCIRENT CLINICAL RESEARCH AND SCIENCE D.O.O. BEOGRAD-VRACAR – Trademark Portfolio
Entity Type: 99
SCIRENT CLINICAL RESEARCH AND SCIENCE D.O.O. BEOGRAD-VRACAR holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SCIRENT CLINICAL RESEARCH AND SCIENCE.
Alekse Nenadovica 31/10
11000 Beograd
Showing of trademarks Trademarks
Trademark Classifications
SCIRENT CLINICAL RESEARCH AND SCIENCE D.O.O. BEOGRAD-VRACAR's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does SCIRENT CLINICAL RESEARCH AND SCIENCE D.O.O. BEOGRAD-VRACAR have?
SCIRENT CLINICAL RESEARCH AND SCIENCE D.O.O. BEOGRAD-VRACAR has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does SCIRENT CLINICAL RESEARCH AND SCIENCE D.O.O. BEOGRAD-VRACAR file in?
SCIRENT CLINICAL RESEARCH AND SCIENCE D.O.O. BEOGRAD-VRACAR files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.
What are SCIRENT CLINICAL RESEARCH AND SCIENCE D.O.O. BEOGRAD-VRACAR's most well-known trademarks?
SCIRENT CLINICAL RESEARCH AND SCIENCE D.O.O. BEOGRAD-VRACAR's registered trademark portfolio includes well-known marks such as SCIRENT CLINICAL RESEARCH AND SCIENCE. These are among 1 currently registered trademark in the portfolio.
What is SCIRENT CLINICAL RESEARCH AND SCIENCE D.O.O. BEOGRAD-VRACAR's trademark registration success rate?
SCIRENT CLINICAL RESEARCH AND SCIENCE D.O.O. BEOGRAD-VRACAR has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.